Literature DB >> 8420831

Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency.

C J Kara1, L H Glimcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8420831     DOI： 10.1007/bf00191890

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  10 in total

1.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.

Authors:  P R Mueller; B Wold
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome.

Authors:  C J Kara; L H Glimcher
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

3.  Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene.

Authors:  P Gönczy; W Reith; E Barras; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

4.  Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors.

Authors:  C R Hume; J S Lee
Journal:  Hum Immunol       Date:  1989-12       Impact factor: 2.850

5.  A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.

Authors:  B Lisowska-Grospierre; D J Charron; C de Préval; A Durandy; C Griscelli; B Mach
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.

Authors:  B Bénichou; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes.

Authors:  C de Préval; B Lisowska-Grospierre; M Loche; C Griscelli; B Mach
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

8.  Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.

Authors:  C de Préval; M R Hadam; B Mach
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

9.  An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.

Authors:  S J Ono; V Bazil; M Sugawara; J L Strominger
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Authors:  Z Yang; R S Accolla; D Pious; B J Zegers; J L Strominger
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598
  10 in total
  12 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  Definition of a novel complementation group in MHC class II deficiency.

Authors:  A Peijnenburg; B Godthelp; A van Boxel-Dezaire; P J van den Elsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model.

Authors:  M W Linhoff; K L Wright; J P Ting
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.

Authors:  A Osborne; H Zhang; W M Yang; E Seto; G Blanck
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  MHC class II gene expression is not induced in HPIV3-infected respiratory epithelial cells.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  Differential expression of HLA-DQB1 alleles in a heterozygous cell line.

Authors:  G T Nepom; J Chung; K A West
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.

Authors:  J Villard; M Peretti; K Masternak; E Barras; G Caretti; R Mantovani; W Reith
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

Authors:  C H Chang; J D Fontes; M Peterlin; R A Flavell
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.

Authors:  J Douhan; I Hauber; M M Eibl; L H Glimcher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.